Optiscan

Good coverage in The West and @BullsNBearsWA today. Learn more: optiscan.com #digitalpatholology #imageguidedsurgery #singlecellimaging #imaginethepossibilities #thewest #optiscanimaging #invivage

Delighted to be attending #CellBio23 in Boston. Looking forward to connecting with attendees and establishing new connections for our unique handheld, slide-free, non-destructive #viewnvivo single-cell imaging technology. #seelifeconnected #CellBiology #CellBio #optiscanimaging

Learn more about our business, technology, and get glimpse into the future of digital pathology and precision surgery in this expert report from @stockhead #optiscanimaging #digitalpathology #Robotics

Delighted to be collaborating with Design + Industry in developing our new product portfolio. With 260 industry awards over 35 years, we look forward to perfecting our new devices for clinicians, health systems and patients. #imaginethepossibilities #digitalpathology

Optiscan Imaging Ltd wishes all our US colleagues, clinicians, partners, friends, and their families a wonderful #Thanksgiving. We hope your day is filled with warmth, happiness, and the company of those closest to you.

@StockheadAU For further information on our technology, please visit optiscan.com & follow our media channels for regular updates.

Optiscan’s platform could address global pathologist shortage bit.ly/3urSu9e #ad #ASX #ASX200 $OIL @Optiscan_

Following news about a global shortage of pathologists, we have been featured in a special report by @StockheadAU today. #optiscanimaging #digitalpathology #imaginethepossibilities Read: stockhead.com.au/tech/optiscans…

Optiscan Imaging Ltd has released its Quarterly Report and Appendix 4C for the quarter ended 30 September 2023. Read: optiscan.com/investor/asx-a… #optiscanimaging #asx

Delighted to announce a special report on our company in #stockhead today. Learn more: optiscan.com #optiscanimaging #digitalpathology #imaginethepossibilities stockhead.com.au/health/diagnos…

Delighted to welcome Brendan Fafiani as our new Chief Operating Officer. Mr Fafiani will lead operations at our Melbourne headquarters, our operational planning, commercialisation strategy, customer and development efforts. Read: optiscan.com/investor/asx-a… #optiscanimaging #ASX

@BullsNBearsWA @OptiScan For further updates follow us at @Optiscan_. To learn more visit optiscan.com.

Melbourne-based @Optiscan has strengthened its mission aimed at breaking into the US health market with its “ViewnVivo” technology. $OIL #OptiscanImaging #BULLSNBEARSWA #ASX #Medtech #ViewnVivo thewest.com.au/business/bulls…

@westaustralian Follow @Optiscan_ for regular updates or visit optiscan.com to learn more.

Optiscan Imaging has strengthened its mission aimed at breaking into the US health market with its “ViewnVivo” technology by putting two key personnel on the ground on that country’s respective east and west coasts. #BULLSNBEARSWA bit.ly/48Pyi0n

Delighted to announce the appointment of Tim Rowe and Shayra Leon as our new Business Development Managers for North America. Read: optiscan.com/investor/asx-a… #asx #optiscanimaging

Pleased to announce interim readout on our Breast Cancer Intraoperative Assessment Study, revealing excellent correlation between our real-time #CLE imaging and traditional histological analysis. Read more: lnkd.in/gXYQ8uf2 #optiscanimaging #digitalpathology #asx

Further coverage by @westaustralian. Visit optiscan.com to learn more.

#Medtech company @Optiscan_ has rounded out a dynamic year with a whopping 66 per cent revenue boost to nearly $1.7 million following the sale of its #ViewnVivo research device to an American pharmaceutical company. $OIL @westaustralian @prolucid thewest.com.au/business/bulls…

@BullsNBearsWA @westaustralian @prolucid Please visit optiscan.com to learn more

We have released our Annual Report FY23, with revenues increasing to $1.68m (+66%) and net cash outflows decreasing from $3.8m to $3.2m. We thank all our collaborators, shareholders, and employees for their ongoing support & look forward to FY24. optiscan.com/investor/asx-a…

#Medtech company @Optiscan_ secures $16.7m research and development funding $OIL #OptiscanImaging #BULLSNBEARSWA #ASX #3DImaging #SaMD #DigitalPathology #ProlucidTechnologies thewest.com.au/business/publi…

Further coverage in Bulls N' Bears today #digitalpathology #imaginethepossibilities #AI #telepathology